Difficulty: Medium
Average Score: 74%
Practice
Patients receiving heparin therapy require monitoring of:
Correct answer
A
Rationale
In patients receiving heparin therapy, monitoring platelet levels every two to three days for thrombocytopenia that may occur on day four of therapy is crucial. Thrombocytopenia is a potential side effect of heparin therapy due to immune-mediated platelet destruction, which can lead to serious complications like thrombosis. Therefore, close monitoring allows for early detection and intervention to prevent adverse outcomes.
Option A is correct because it addresses a specific and common complication associated with heparin therapy, highlighting the importance of regular platelet monitoring to ensure patient safety.
Options B, C, and D are incorrect because they do not directly relate to the monitoring requirements of heparin therapy. Monitoring electrolytes for elevated potassium levels, INR levels, or blood pressure is not typically associated with heparin therapy specifically.
In an educational context, understanding the rationale behind monitoring requirements in heparin therapy is essential for healthcare professionals to provide safe and effective care to patients. By emphasizing the significance of regular platelet monitoring, this question reinforces the need for vigilant monitoring practices in hematology to prevent and manage potential complications.
Option A is correct because it addresses a specific and common complication associated with heparin therapy, highlighting the importance of regular platelet monitoring to ensure patient safety.
Options B, C, and D are incorrect because they do not directly relate to the monitoring requirements of heparin therapy. Monitoring electrolytes for elevated potassium levels, INR levels, or blood pressure is not typically associated with heparin therapy specifically.
In an educational context, understanding the rationale behind monitoring requirements in heparin therapy is essential for healthcare professionals to provide safe and effective care to patients. By emphasizing the significance of regular platelet monitoring, this question reinforces the need for vigilant monitoring practices in hematology to prevent and manage potential complications.